![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | G01N 33/566 | |
C07K 16/28 |
(11) | Patento numeris | 3304079 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16731700.7 |
Europos patento paraiškos padavimo data | 2016-06-02 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-04-11 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-06-03 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/035514 |
Data | 2016-06-02 |
(87) | Numeris | WO 2016/196792 |
Data | 2016-12-08 |
(30) | Numeris | Data | Šalis |
201562170579 P | 2015-06-03 | US |
(72) |
WANG, Xi-tao, US
ADELAKUN, Olufemi, A., US
LEWIN, Anne, C., US
KORMAN, Alan, J., US
SELBY, Mark, J., US
WANG, Changyu, US
HUANG, Haichun, US
HENNING, Karla, A., US
LONBERG, Nils, US
SRINIVASAN, Mohan, US
HAN, Michelle, Minhua, US
CHEN, Guodong, US
HUANG, Richard, US
CHAKRABORTY, Indrani, US
WONG, Susan, Chien-Szu, US
LI, Huiming, US
|
(73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
(54) | ANTI-GITR ANTIBODIES FOR CANCER DIAGNOSTICS |
ANTI-GITR ANTIBODIES FOR CANCER DIAGNOSTICS |